Phase Forward, the US-based provider of data management solutions for clinical trials and drug safety, has been ranked 16th in this year’s Globe 100 list of top-performing public companies in the US state of Massachusetts.

The ranking was based on a composite score derived from financial data for the four quarters ended 31 December 2007. This is the second time Phase Forward has been included in the Globe 100, which is compiled annually by the Boston Globe newspaper. It highlights the leading Massachusetts-based companies whose shares are publicly trading on NASDAQ, the New York Stock Exchange or the American Stock Exchange.

Phase Forward has its home base in Waltham, Massachusetts, where it will move to new, larger headquarters later this year. For 2007, the company reported revenues of US$134.3 million, up by 26% over the previous year, and operating income 40% higher at US$13.0 million.

“As a software and service company providing products to the life sciences industry, Phase Forward is at a unique intersection – one that allows us to draw on two thriving local Massachusetts markets,” noted president and chief executive officer Bob Weiler. “The state’s strong roots in technology provide a natural foundation for companies like Phase Forward, as well as an inherent spirit of innovation and collaboration of which we’re proud to be a part.”